missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Thermo Scientific™ LanthaScreen™ Tb-anti-LRRK2 [pSer935] Antibody
This assay format provides a convenient tool for the expression of LRRK2-GFP fusion protein in the cell background of the user's choice. The resulting cellular assay can be used to identify LRRK2 and relevant mutant inhibitor.
Brand: Thermo Scientific™ A14693
This item is not returnable.
View return policy
Description
- The LanthaScreen™ Tb-Anti-LRRK2 [pSer935] Antibody allows the investigation of phosphorylation at serine 935 on LRRK2 protein kinase
- When paired with LRRK2 BacMam reagents, users have the freedom to choose the cellular background for their assay, including primary cells
- This enables screening for potential inhibitors of LRRK2 proteins in their natural complexes in a physiologically relevant cell type
- This antibody has been specifically developed and optimized for use in our LanthaScreen™ TR-FRET LRRK2 Cellular Activity Assay Kits
- The antibody, as well as other components of these assay kits, are also available separately
- Can be used by Parkinson's and other disease researchers to perform HTS, cell-based assays to generate inhibition curves (IC50) for their compound libraries
- This will aid drug discovery efforts by reducing the time to results from 4 hrs to typically 1.5 hrs compared to alternative ELISAs
- For research use only
- Not intended for animal or human diagnostic or therapeutic use
Specifications
| Monoclonal | |
| NP_940980.3 | |
| 100 μg | |
| 1 tube LanthaScreen™ Tb-anti-LRRK2 [pSer935] Antibody 100 μg, Store at -20 °C | |
| Rb | |
| Dry Ice | |
| Phospho | |
| LanthaScreen |
| Tb (Terbium)/Lanthanide Chelates | |
| Rabbit | |
| 120892 | |
| HTS Reader | |
| Human | |
| Hu | |
| LRRK2 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction